Literature DB >> 9592594

Inhibitory effect of shofu-san, a Japanese kampo medicine, on neutrophil functions in vitro.

H Akamatsu1, Y Asada, T Horio.   

Abstract

The effect of Shofu-san (TJ-22), an oral Japanese kampo medicine, on several inflammatory parameters of human neutrophils, including reactive oxygen species (ROS) generation, chemotaxis, and calcium concentration, [Ca2+]i in neutrophils was examined in vitro. In addition, ROS generated in a cell-free, xanthine-xanthine oxidase system was also assessed. The species investigated were superoxide radical anion (O2-), hydrogen peroxide (H2O2), and hydroxyl radical (OH.). TJ-22 significantly decreased neutrophil-generated O2-, H2O2 and OH. in a dose-dependent manner. The medicine also markedly inhibited neutrophil chemotaxis and [Ca2+]i in neutrophils. In addition, three kinds of ROS generated in the cell-free system was reduced in the presence of TJ-22. Our results indicate that TJ-22 may exert an anti-inflammatory action by inhibiting the neutrophil functions and scavenging ROS, leading to a reduction in oxidative tissue injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9592594     DOI: 10.1142/S0192415X98000087

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

1.  Kampo Medicines for Mite Antigen-Induced Allergic Dermatitis in NC/Nga Mice.

Authors:  Xiu Kun Gao; Kazutoshi Fuseda; Tomonori Shibata; Hiroyuki Tanaka; Naoki Inagaki; Hiroichi Nagai
Journal:  Evid Based Complement Alternat Med       Date:  2005-03-23       Impact factor: 2.629

2.  Identifying chinese herbal medicine network for eczema: implications from a nationwide prescription database.

Authors:  Hsing-Yu Chen; Yi-Hsuan Lin; Sindy Hu; Sien-Hung Yang; Jiun-Liang Chen; Yu-Chun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-22       Impact factor: 2.629

3.  Characteristics of traditional Chinese medicine users and prescription analysis for pediatric atopic dermatitis: a population-based study.

Authors:  Yu-Chun Chen; Yi-Hsuan Lin; Sindy Hu; Hsing-Yu Chen
Journal:  BMC Complement Altern Med       Date:  2016-06-08       Impact factor: 3.659

4.  An Alternative Approach to Atopic Dermatitis: Part I-Case-Series Presentation.

Authors:  Hiromi Kobayashi; Kuniaki Takahashi; Nobuyuki Mizuno; Haruo Kutsuna; Masamitsu Ishii
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.